Vanessa B. Wookey, MD

Vanessa Wookey, MD, assistant professor in the Department of Hematology/Oncology
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Assistant Professor, Department of Hematology/Oncology

Specialties

Treatment Philosophy

Receiving a cancer diagnosis is a life-changing event. As a medical oncologist specializing in gastrointestinal cancers, it is my responsibility to help patients navigate the complexities and uncertainties of cancer and its therapies with compassion and respect. As every patient is unique and has unique needs, I believe in working together with each patient to develop an individualized plan of care. At Fox Chase Cancer Center, a team of experts in different specialties work together to provide a multidisciplinary and patient-centered approach, which are essential aspects of effective cancer care.

My research focus is improving the current landscape of cancer care by developing new knowledge and treatment strategies for patients with gastrointestinal cancers. At Fox Chase, my patients will have access to clinical trials, in addition to standard therapies for patients with gastrointestinal cancers.

Clinical Locations

Educational Background

  • Advanced Gastrointestinal Oncology Fellowship, Mayo Clinic, Rochester, MN, 2022
  • Hematology/Oncology Fellowship, University of Tennessee Health Science Center: Memphis, TN, 2021
  • Internal Medicine Residency, University of Nebraska Medical Center, Omaha, NE, 2018
  • MD, Sanford School of Medicine at the University of South Dakota, Sioux Falls, SD, 2015
  • Bachelor of Science in Biology, Chemistry minor, South Dakota State University, Brookings, SD, 2010

Certifications

  • American Board of Internal Medicine, Medical Oncology, 2021
  • American Board of Internal Medicine, Internal Medicine, 2018

Memberships

  • American Society of Clinical Oncology, Member, 2017-present
  • American Medical Association, Member, 2011-present
  • American Society of Hematology, Member, 2018-present

Honors & Awards

  • Scholarship Pathways Program, Sanford School of Medicine, Sioux Falls, SD. 2012-2015.
  • Avera Health Scholarship, 2011-2015.
  • SDSMA DakotaCare Scholarship, 2013-2014.
  • Faithe Opportunity Scholarship, 2013-2014.
  • Dr. Walter Hard Excellence in Anatomy Scholarship, 2012.

Selected Publications

Wookey V, Hall M. Detecting molecular residual disease to inform CRC treatment: are we ready for universal postoperative ctDNA screening? ASCO Daily News. June 16, 2022.

Gile J, Wookey V, Zemla T, Hassan H, Shi Q, Borad M, Bekaii-Saab T, Tran N, Mahipal A. Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma: Multi-center single institution cohort experience. Poster Presentation. European Society for Medical Oncology World Congress on Gastrointestinal Cancer Annual Meeting. Barcelona, Spain, June 2022.

Soderberg L, Wookey V, Mitchell J, Jochum J, Tran N, Halfdanarson T, Hubbard J, Graham R, Mathis K, Mahipal A, Jin Z. Clinical outcomes of neoadjuvant treatment strategies in localized mismatch repair-deficient rectal cancer. Poster Presentation. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 2022.

Wookey V, Mehler S, Stein M, Norton A, Grothey A, Somer B. “Impact of circulating tumor DNA (ctDNA) on clinical decisions in the adjuvant setting in patients with colorectal cancer (CRC)”. Poster Presentation. European Society for Medical Oncology World Congress on Gastrointestinal Cancer Annual Meeting [Virtual]. July 2021.

Wookey V, Schwartzberg L. Chapter 52: Hematologic support of the cancer patient; pp 766-784. In Principles and Practice of Palliative Care and Supportive Oncology, 5th edition: Wolters Kluwer; Philadelphia, PA; 2021. Ed: Berger AM, O’Neill JF.

Wookey V, Grothey A. Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer. Therap Adv Gastroenterol. June 2020; 14: 1-9.

Wookey V, Bufalino G, Vidal G, Somer B, Schwartzberg L, Grothey A. “Racial and Socioeconomic disparities in overall survival in colorectal cancer (CRC) at West Cancer Center (WCC), Memphis, TN”. Poster Presentation. American Society of Clinical Oncology Gastrointestinal Cancers Symposium. San Francisco, CA, January 2020.

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​
Resize Text

Related Articles